Misleading promotions of GLP-1 and compounded semaglutide products are drawing renewed regulatory scrutiny over risk ...

The U.S. Food and Drug Administration issued warning letters to Eli Lilly, Novo Nordisk and telehealth firm Hims & Hers ...

For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — ...

Stocks closed slightly lower Tuesday, a day before the Federal Reserve's decision on interest rates. The Nasdaq and S&P 500 ...

United Pharma Marketing, PR & Communications, New Product Planning & Commercialization and Medical Affairs Communities to ...

GoodRx Holdings offers compelling value after a 50% drop and a new deal despite recent execution challenges. Click here to ...

President Trump ordered the FDA to enforce rules on direct-to-consumer drug ads, after HHS Secretary Robert F. Kennedy Jr.

Hall 2, 3 & 4, Pragati Maidan, New Delhi * Visitor Pass: Free entry to the Medicall Expo, New Delhi with a free visitor pass.

The U.S. Food and Drug Administration has sent a letter to Novo Nordisk (NVO) CEO Maziar Mike Doustdar regarding the company’s promotional communication featuring Oprah Winfrey, alleging that the ...

Soleno said that its assessment of the death is the same as the treating physician, who said that the death is not related to ...

Hims & Hers' scalable model, product launches, and global expansion plans support its ambitious 2030 revenue and EBITDA ...

A retired four-star U.S. Navy admiral was sentenced on Tuesday to six years in prison for his conviction on corruption ...